Hyperosmotic oral replacement fluid for diarrheic calves.
Twenty-five diarrheic neonatal calves, none of which was recumbent, were used to determine oral efficacy of a commercial product for fluid replacement, either by suckle or intubation. Changes in plasma protein, glucose, sodium, potassium, and osmolality as well as blood lactate and PCV were measured. Core body temperature and surface temperature at the hock and fetlock were monitored. Data were analyzed for interaction with time and response according to clinical condition. Significant differences (P less than 0.05) following therapy were restricted to glucose and potassium changes. Beneficial posttreatment trends were observed in cutaneous temperature, blood lactate, plasma protein, and PCV values.